Barbara Cipriani
Company: Pathios Therapeutics
Job title: VP, Head of Biology
Seminars:
GPR65 Inhibition as a Strategy to Overcome Chronic Acidosis-Mediated Immune Suppression in Solid Tumours & Identification of PTT-4256 as a Clinical Development Candidate 3:30 pm
Genetic validation of GPR65 as an immuno-oncology target PoC studies with tool GR65 inhibitor molecules demonstrating efficacy in pre-clinical tumour models Identification of PTT-4256 as a first in class inhibitor of GPR65 and path to the clinicRead more
day: Conference Day Two
Chair’s Opening Remarks 8:50 am
day: Conference Day One